Top Markets
Coin of the day
American CryoStem Corporation American CryoStem Corporation

American CryoStem Corporation

CRYO
주식 순위 #42083
American CryoStem Corporation (ACSC) specializes in the development,... American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners. The company also provides the ATGRAFT service, a comprehensive solution for harvesting, processing, and preserving adipose tissue, enabling physicians to offer patients versatile options for tissue products and cellular banking. Complementing these are ATCELL, a line of proprietary adipose-derived stem cells, and ACSelerat cell culture media, specifically formulated to promote the growth of human stromal cells. Furthermore, American CryoStem extends its expertise through contract manufacturing services for specific formulations, including Autokine-CM, an anti-aging topical product, and a unique autologous skin care range. Founded in 1987, American CryoStem Corporation is headquartered in Eatontown, New Jersey.
주가
$0.0001
마지막 동기화: 2024-04-02
시가총액
$5.03K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 American CryoStem Corporation (CRYO)

카테고리

American CryoStem Corporation (CRYO)의 주가 이력
최고 종가: $0.00 (2024-04-01 기준)

최저 종가: $0.45 (2010-11-01 기준)
American CryoStem Corporation의 주가 이력 (2010 ~ 2026)
연간 주가 성과
연도 성과
2024 -75.90%
2023 -99.67%
2022 -83.84%
2021 116.36%
2020 14.71%
2019 -38.73%
2018 -40.12%
2017 226.07%
2016 21.68%
2015 -50.88%
2014 183.90%
2013 -70.02%
2012 -31.43%
2011 19.88%
2010 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.52%
KR